- George Wilding
Infobox Person
image_size = 150px
name = George Wilding, MD
caption =
birth_date =
birth_place =
occupation = Director, Paul P. Carborne Comprehensive Cancer Center, Anderson Professor of Clinical Oncology, UW-Madison
spouse =George Wilding is a Director of the Paul P.
Carbone Comprehensive Cancer Center andAnderson Professor ofClinical Oncology of the Department of Medicine ofUW-Madison and an internationally recognized leader and clinician in the fields ofoxidative stress andprostate cancer prevention and therapy. He is a member of the Editorial Board of the Journal “The Prostate”.Dr. Wilding is the principal inventor of
Colby Pharmaceutical Company [http://www.colbypharma.com/pipeline/lead_pipeline_drugs/cpc_100_a.html CPC-100] prostate cancer therapeutic drug and a major collaborator with Dr.Hirak Basu in the invention of [http://www.colbypharma.com/pipeline/lead_pipeline_drugs/cpc_200_a.html CPC-200] . As the currentUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Center Director of Clinical Research, he overseespeer-reviewed cancer research funding atUWCCC . About 250 clinical trials are available for patient enrollment at the Cancer Center with more than 700 patients participating each year.Dr. Wilding, graduated from the
University of Massachusetts Medical School where he also completed his training inInternal Medicine . He underwent training in Medical Oncology at theNational Cancer Institute . He joined the UW School of Medicine and Public Health faculty to focus on the development of new cancer therapies, particularly aimed at progressive and advanced prostate cancer. He is currently the principal investigator on grants funded by the National Cancer Institute, Department of Defense, and private foundations, such asProstate Cancer Foundation , etc. His research teams are conducting studies in the laboratory and in the clinics aimed at developing and testing new cancer treatments. New therapies targetingangiogenesis ,cell signaling anddifferentiation are now being tested. All of these areas of investigation are tightly linked to laboratory research groups to provide a strong basic science foundation for translational research.See also
*
Reactive Oxygen Species
*Oxidative Stress
*Prostate Cancer External links
* [http://www.colbypharma.com/about_colby/scientific_advisory_board/george_wilding_md.html George Wilding, MD, Co-Chairman of Colby Pharmaceutical Company Scientific Advisory Board]
Wikimedia Foundation. 2010.